Eko Analysis Software vs DeepRhythmAI
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if you are a clinician seeking an integrated solution for real-time, point-of-care cardiovascular screening and remote monitoring. It is ideal for primary care, emergency medicine, or telehealth, allowing you to combine digital auscultation with AI-powered detection of heart murmurs and AFib directly during patient encounters and save recordings for later review.
View Eko Analysis Software →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your primary need is highly accurate and efficient AI-powered analysis and classification of large volumes of existing ECG data. This cloud-based algorithm is best suited for cardiology practices or health systems that require a device-agnostic solution to streamline ECG reporting, significantly reduce missed arrhythmia diagnoses, and improve overall workflow efficiency.
View DeepRhythmAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | DeepRhythmAI |
|---|---|---|
| Pricing | Freemium with subscription for full features | Contact vendor for pricing information |
| Deployment | Cloud-based | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software (Tool A) integrates with Eko's digital stethoscopes and a mobile app, offering a direct and intuitive user experience at the point of care for clinicians. DeepRhythmAI (Tool B) is a cloud-based algorithm with an API, designed for integration into third-party software and devices, and explicitly states it 'doesn't have User Interface', making it less directly usable by an end-user clinician without another system.
Clinical Value
DeepRhythmAIDeepRhythmAI (Tool B) boasts impressive, quantified clinical outcomes, claiming to reduce missed diagnoses by 14x to 114x and increase workflow efficiency by up to 65%. It is trained on an exceptionally large dataset of over 250 billion annotated heartbeats. While Eko Analysis Software (Tool A) provides valuable FDA-cleared detection for murmurs and AFib, Tool B's specific metrics and extensive training data suggest a potentially higher and more proven clinical impact in its specialized domain of arrhythmia detection and classification.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software (Tool A) offers a transparent freemium model with a subscription for full features, allowing users to experience basic functionalities before committing to a paid plan. DeepRhythmAI (Tool B) is described as having an 'enterprise' pricing model with unknown details, which typically implies less flexibility and transparency for individual practitioners or smaller organizations.
Enterprise Readiness
DeepRhythmAIDeepRhythmAI (Tool B) is explicitly designed for enterprise integration, featuring an API, data export capabilities, and a target market ranging from solo practitioners to large health systems, with numerous global customers. It also mentions compliance with HIPAA, GDPR, HITECH, and SOC 2. While Eko Analysis Software (Tool A) is HIPAA compliant and has a BAA, Tool B's comprehensive integration features and broader enterprise focus make it more robust for large-scale deployments.
Innovation
DeepRhythmAIDeepRhythmAI (Tool B) utilizes advanced AI models like Convolutional Neural Networks (CNN) and Transformer models, trained on an enormous dataset of over 250 billion annotated heartbeats, indicating significant technological innovation in its core AI engine. Eko Analysis Software (Tool A) is innovative in its integration with digital stethoscopes and mobile app for point-of-care diagnostics, but Tool B's deep learning methodology and massive training data represent a more cutting-edge approach to AI in cardiac diagnostics.
Support & Docs
Eko Analysis SoftwareEko Analysis Software (Tool A) benefits from Eko Health's comprehensive and publicly accessible support resources, including a help center with FAQs, user manuals, live Q&A sessions, and direct contact options. DeepRhythmAI (Tool B), being an enterprise-focused solution without a native user interface, has less publicly available direct user support or documentation, relying more on integration partners and direct enterprise agreements.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | DeepRhythmAI |
|---|---|---|
| Name | Eko Analysis Software | DeepRhythmAI |
| Company | Eko Devices | Medicalgorithmics S.A. |
| Primary AI Detections | Heart murmur detection, Atrial fibrillation (AFib) detection, Normal sinus rhythm detection | Cardiac arrhythmia detection and classification |
| Device Compatibility | Eko's digital stethoscopes, Bluetooth-enabled devices | Device-agnostic, integrates with various ECG devices |
| Mobile App | Available | None |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and DeepRhythmAI.